InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Earnhardt Lisa D, Chief Executive Officer. Insider active across 2 companies, notably Abbott Laboratories. Cumulatively, 17 disclosures have been published. Split: 0 buy · 2 sells. Total volume traded: €2.3m. History available since 10 June 2021. The latest transaction was filed on 27 February 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Earnhardt Lisa D
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
8,577 shares@ US$116.265.3% of flowCommon shares without par valueSEC:0001530893-26-000004:0
27,056 shares0Common shares without par valueSEC:0001530893-26-000002:0
91,167 shares@ US$80.9842.6% of flowCommon shares without par valueSEC:0001415889-25-007453:0
8,322 shares@ US$135.876.8% of flowCommon shares without par valueSEC:0001415889-25-006743:0
18,788 shares0Common shares without par valueSEC:0001415889-25-005886:0
22,852 shares@ US$106.254114.1% of flowCommon shares without par valueSEC:0001415889-24-012624:0
7,669 shares@ US$120.055.3% of flowCommon shares without par valueSEC:0001415889-24-006405:0
17,240 shares0Common shares without par valueSEC:0001415889-24-005098:0
7,631 shares@ US$99.774.5% of flowCommon shares without par valueSEC:0001415889-23-003901:0
15,855 shares0Common shares without par valueSEC:0001415889-23-003050:0
19,592 shares@ US$112.7112.9% of flowCommon shares without par valueSEC:0001415889-22-006538:1
2,882 shares@ US$112.710.0001% mcap22.0% of flowCommon shares without par valueSEC:0001415889-22-006538:0
5,168 shares@ US$122.413.6% of flowCommon shares without par valueSEC:0001415889-22-002190:0
17,247 shares0Common shares without par valueSEC:0001415889-22-001734:0
2,881 shares@ US$109.051.6% of flowCommon shares without par valueSEC:0001415889-21-002958:0
8,000 sharesCommon StockSEC:0001562180-16-001352:0
12,500 sharesCommon StockSEC:0001562180-16-001352:1
17 of 17 declarations
About Earnhardt Lisa D
Lisa D Earnhardt is Directeur Général, and their 17 filings relate to Abbott Laboratories and Intersect ENT, Inc. In the recent filings we hold, there were no purchases, sales total 2258612 EUR, and the period runs from 2016-01-20 to 2026-03-03. The most frequent transaction nature is Retenue fiscale.
